Comorbidities and treatment decisions in myelofibrosis

John Mascarenhas, MD, The Mount Sinai Hospital, New York, NY, comments on competing comorbidities in patients with myelofibrosis (MF), highlighting the impact of these comorbidities on treatment decisions and emphasizing the role of a multidisciplinary team in such decisions. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.